Amta Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMTA, and what generic and branded alternatives to AMTA drugs are available?
AMTA has ten approved drugs.
Drugs and US Patents for Amta
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amta | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 216304-002 | Aug 8, 2022 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Amta | TROSPIUM CHLORIDE | trospium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 214760-001 | Apr 30, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Amta | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216439-005 | Mar 7, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Amta | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212026-003 | Jan 6, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Amta | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212026-001 | Jan 6, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Amta | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216439-006 | Mar 7, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.